Consistent with the reports regarding various human cancers [15–24], we demonstrated for the first time that CA-IX-positive HCCs were associated with significantly lower DFS and OS than CA-IX-negative HCCs in patients with resectable tumors. The gene discussed is CA9; the disease is cancer.